Stocks · Healthcare · Biotechnology
Vir Biotechnology, Inc. VIR
$11.17 -1.06% Close, Oct 2, 2026 · NASDAQ · Market cap $1.88B
Strong growthStrong trend
Next earnings report: Nov 4, 2026
Scroll or pinch to zoom, drag to move. Daily prices adjusted for splits. Markers: E = earnings (green beat, red miss), S = split, D = dividend.
Three things to know
- Revenue over the last four quarters was $303.2M, up 1495.9% from a year earlier, accelerating from 214.0% a quarter earlier.
- Operating margin widened to -89.0% from -3191.7% a year earlier.
- The diluted share count rose 22.0% in a year.
PromtFinance scores
Each score is a percentile within the Healthcare sector (0–100). Under each score: how the stock ranks in its sector on every component. As of Oct 5, 2026.
How fast revenue, earnings and cash flow are growing.
- Revenue growth (TTM, YoY)Top 3%
- Revenue growth, 3-year CAGRBottom 2%
- Revenue growth accelerationTop 1%
Returns on capital, margins, earnings quality and balance-sheet strength.
- Return on invested capitalBottom 47%
- Gross marginTop 1%
- Operating marginBottom 30%
- Accruals (lower is better)Bottom 9%
How cheap the shares are relative to earnings, cash flow and their own history.
- Earnings yieldBottom 37%
- Free-cash-flow yieldBottom 27%
- EBITDA / enterprise valueBottom 32%
- Sales / enterprise valueBottom 45%
Strength and persistence of the price trend, including versus the S&P 500.
- 12-month return excluding last monthTop 17%
- 6-month returnTop 37%
- 1-year return vs S&P 500Top 16%
- Distance from 52-week highTop 8%
- Trend checklist (0–4)Top 7%
Earnings surprises and analyst sentiment (estimate-revision history is being collected).
- Average EPS surprise, last 4 quartersBottom 5%
- Consecutive EPS beatsBottom 49%
- Share of analysts rating BuyTop 38%
- Upside to consensus price targetTop 31%
Low volatility, shallow drawdowns, low market sensitivity and modest leverage.
- Volatility, 60 days (lower is better)Top 35%
- Maximum drawdown, 3 yearsTop 44%
- Beta vs S&P 500 (lower is better)Top 24%
What changed
Latest four quarters versus the same period a year earlier (growth: versus one quarter earlier).
| Measure | Before | Now | |
|---|---|---|---|
| Revenue growth (YoY) | 214.0% | 1495.9% | ↑ |
| Gross margin | -2527.1% | 170.0% | ↑ |
| Operating margin | -3191.7% | -89.0% | ↑ |
| FCF margin | -2454.6% | -109.3% | ↑ |
Fundamental momentum
| Measure | Now (TTM) | Year / quarter before | Sector rank | |
|---|---|---|---|---|
| Revenue growth (TTM, YoY) | 1495.9% | 214.0% | ↑ | Top 3% |
| Gross margin | 170.0% | -2527.1% | ↑ | Top 1% |
| Operating margin | -89.0% | -3191.7% | ↑ | Bottom 30% |
| Net margin | -83.0% | -2895.9% | ↑ | — |
| Free-cash-flow margin | -109.3% | -2454.6% | ↑ | — |
| Return on invested capital | -23.9% | — | Bottom 47% | |
| Revenue growth, 3-year CAGR | -65.1% | — | Bottom 2% |
Quality of earnings and balance sheet
- Accruals (net income − OCF) / assetsLower is better; high accruals can signal weaker earnings quality.
- 6.8%
- Stock-based compensation / revenueA cost to shareholders through dilution.
- 15.5%
- Net debt / EBITDABelow 1× is conservative; above 3× is high leverage.
- Net cash
Shareholder returns
- Dividend yield (dividends paid, TTM)
- 0.00%
- Net buyback yield (TTM)
- -21.93%
- Shareholder yield
- -21.93%
- Share count change, 1 year
- +22.0%
- Share count change, 3-year CAGR
- +8.0%
Shareholder yield = dividends + net buybacks over the last four quarters, divided by market cap.
Based on the four quarters through Jun 30, 2026 (filed Aug 5, 2026).
Earnings and expectations
Earnings momentum
- Consecutive EPS beats
- 1
- Beats in the last 8 reports
- 3 of 8
- Average EPS surprise, last 4
- -100.0%
- Average 2-day reaction, last 8
- +0.2%
- Positive 20 days after report
- 5 of 8
Analysts
- Consensus price target
- $25.00
- Target vs current price
- +123.8%
- Analysts with a rating
- 12
- Share rating Buy or Strong Buy
- 83%
- Consensus rating
- Buy
How the stock reacted to recent reports
| Report date | EPS surprise | 2 days | 5 days | 20 days | 60 days |
|---|---|---|---|---|---|
| Aug 5, 2026 | +41.3% | -0.7% | -2.6% | +26.8% | — |
| May 6, 2026 | -8400.0% | +2.8% | -6.1% | -12.4% | -13.5% |
| Feb 23, 2026 | +26.2% | -1.7% | +20.2% | +20.4% | +16.0% |
| Nov 5, 2025 | -67.1% | +2.9% | +8.8% | +19.4% | +46.9% |
| Aug 6, 2025 | -11.1% | -0.6% | -14.7% | +7.8% | +15.7% |
| May 7, 2025 | -6.0% | -0.4% | -16.5% | -6.2% | -10.7% |
| Feb 26, 2025 | +10.6% | +1.1% | -9.9% | -23.6% | -50.4% |
| Oct 31, 2024 | -62.5% | -1.4% | +33.8% | +3.4% | +43.4% |
Returns from the close before each report. Past reactions do not determine future ones.
Earnings history
| Report date | EPS | Estimate | Surprise | Revenue |
|---|---|---|---|---|
| Aug 5, 2026 | $0.47 | $0.33 | +41.3% | $238.9M |
| May 6, 2026 | -$0.85 | -$0.01 | -8400.0% | -$29,000 |
| Feb 23, 2026 | -$0.31 | -$0.42 | +26.2% | $64.1M |
| Nov 5, 2025 | -$1.17 | -$0.70 | -67.1% | $240,000 |
| Aug 6, 2025 | -$0.80 | -$0.72 | -11.1% | $1.2M |
| May 7, 2025 | -$0.88 | -$0.83 | -6.0% | $1.8M |
| Feb 26, 2025 | -$0.76 | -$0.85 | +10.6% | $12.4M |
| Oct 31, 2024 | -$1.56 | -$0.96 | -62.5% | $2.4M |
Valuation in context
| Multiple | Now | 5-year median | 5-year percentile | Sector rank (cheapness) |
|---|---|---|---|---|
| EV / Sales | 5.60× | — | — | Bottom 45% |
| Free-cash-flow yield | -17.60% | — | — | Bottom 27% |
| Earnings yield | -16.65% | — | — | Bottom 37% |
P/E over the past five years
Range 2.3× – 6.5× since Dec 31, 2021. Each point: price on the filing date divided by trailing-twelve-month EPS known then.
Technical state
Trend checklist
- ✓ Price above 20-day average
- ✓ Price above 50-day average
- ✓ Price above 200-day average
- ✓ 50-day average above 200-day
- ✗ MACD histogram positive
Trend quality
- Days above the 50-day average
- 30
- Days above the 200-day average
- 209
- 50-day average slope (20 days)
- +4.4%
- 200-day average slope (20 days)
- +5.5%
- Distance from 50-day average
- +10.2%
- Distance from 200-day average
- +23.8%
- RSI (14)
- 56.6
- Relative volume
- 1.05×
Risk and drawdowns
- Volatility, 60 days (annualized)
- 47.2%
- Volatility vs own 5-year history
- 13th percentile · Low for this stock
- Beta vs S&P 500 (2 years, weekly)
- 0.66
- Correlation with S&P 500
- 0.14
- Current drawdown from 1-year high
- -4.0%
- Maximum drawdown, 3 years
- -66.2%
Largest declines in the past six years
| From peak | To low | Decline | Length | Recovery |
|---|---|---|---|---|
| Jan 27, 2021 | Aug 11, 2025 | -94.8% | 1139 days | Not yet recovered |
| Oct 12, 2020 | Nov 9, 2020 | -41.2% | 20 days | 51 days (Jan 25, 2021) |
| Sep 29, 2020 | Oct 2, 2020 | -11.7% | 3 days | 1 days (Oct 5, 2020) |
Declines of 10% or more from a closing high, measured on daily closes.
Financial statements
- Market cap
- $1.88B
- EPS, diluted (TTM)
- -$1.86
- Revenue (TTM)
- $303.2M
- 52-week range
- $4.82 – $11.94
| FY 2021 | FY 2022 | FY 2023 | FY 2024 | FY 2025 | |
|---|---|---|---|---|---|
| Revenue | $1.10B | $1.62B | $86.2M | $74.2M | $68.6M |
| Gross profit | $581.5M | $994.8M | -$486.6M | -$404.4M | $56.9M |
| Operating income | $420.8M | $833.1M | -$684.3M | -$587.2M | -$468.0M |
| Net income | $528.6M | $515.8M | -$615.1M | -$522.0M | -$438.0M |
| EPS (diluted) | $3.96 | $3.83 | -$4.59 | -$3.83 | -$3.16 |
| Q3 2024 | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 | Q4 2025 | Q1 2026 | Q2 2026 | |
|---|---|---|---|---|---|---|---|---|
| Revenue | $2.4M | $12.4M | $3.0M | $1.2M | $240,000 | $64.1M | -$29,000 | $238.9M |
| Net income | -$213.7M | -$104.6M | -$121.0M | -$111.0M | -$163.1M | -$42.9M | -$125.7M | $80.1M |
| EPS (diluted) | -$1.56 | -$0.76 | -$0.88 | -$0.80 | -$1.17 | -$0.31 | -$0.85 | $0.47 |
| FY 2021 | FY 2022 | FY 2023 | FY 2024 | FY 2025 | |
|---|---|---|---|---|---|
| Operating cash flow | -$47.6M | $1.66B | -$778.8M | -$446.4M | -$391.8M |
| Capital expenditure | -$21.8M | -$68.0M | -$21.6M | -$7.3M | -$4.8M |
| Free cash flow | -$69.4M | $1.60B | -$800.4M | -$453.7M | -$396.6M |
| Dividends paid | $0 | $0 | $0 | $0 | $0 |
| Net share buybacks | $85.2M | $28.5M | $7.8M | $4.6M | $4.1M |
Cash outflows are shown as negative numbers.
- Cash and short-term investments
- $528.6M
- Total assets
- $1.21B
- Total liabilities
- $232.3M
- Total debt
- $93.3M
- Net debt
- -$185.5M
- Shareholders’ equity
- $982.5M
As of Jun 30, 2026 (filed Aug 5, 2026).
Short interest
- Shares sold short
- 19,660,671
- Days to cover
- 9.47
- Change vs previous report
- -7.9%
FINRA short interest, settlement date Sep 15, 2026.